SCHEMBL19909109

SCHEMBL19909109

N#Cc1cc(-n2c3ccc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3c3cc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)ccc32)c(-c2ccncc2)c(-n2c3ccc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3c3cc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)ccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.39
RXRG P48443 1/20 0.39
MAPK14 Q16539 3/20 0.37
CSNK1A1 P48729 1/20 0.37
CSNK1D P48730 1/20 0.37
KIF11 P52732 2/20 0.37
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
XDH P47989 1/20 0.33
RIPK3 Q9Y572 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909095 0.95 MAPK14 (0.37) RXRARXRGMAPK14CSNK1A1CSNK1D
SCHEMBL19913170 0.93 RXRA (0.35) RXRARXRGMAPK14CSNK1A1CSNK1D
SCHEMBL19909091 0.91 RXRA (0.39) RXRARXRGMAPK14CSNK1A1CSNK1D
SCHEMBL19903675 0.91 RXRA (0.43) RXRARXRGKIF11CYP11B1CYP11B2
SCHEMBL20617431 0.90 RXRA (0.45) RXRARXRGKIF11CYP11B1CYP11B2
SCHEMBL19908933 0.89 MAPK14 (0.37) RXRARXRGMAPK14CSNK1A1CSNK1D
SCHEMBL19909329 0.89 KIF11 (0.40) MAPK14CSNK1A1CSNK1DKIF11PSEN1
SCHEMBL21414193 0.89 RXRA (0.44) RXRARXRGKIF11CYP11B1CYP11B2
SCHEMBL19903516 0.89 RXRA (0.44) RXRARXRGKIF11CYP11B1CYP11B2
SCHEMBL19913165 0.88 MAPK14 (0.37) RXRARXRGMAPK14CSNK1A1CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 RXRA 3515/4885RXRG 3266/4885MAPK14 2787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.